XML 72 R13.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Note 7 - Accrued Expenses | 12 Months Ended
--- | ---
Dec. 31, 2013
Payables and Accruals [Abstract] |
Accounts Payable and Accrued Liabilities Disclosure [Text Block] | 7. Accrued Expenses Accrued expenses consist of the following:
|  | December 31, |
|  | 2013 |  |  | 2012 |
Payroll and benefits |  | $ | 2,728,616 |  |  | $ | 2,477,833 |
Professional fees |  |  | 383,231 |  |  |  | 642,853 |
Clinical trial costs |  |  | 882,651 |  |  |  | 102,414 |
Research grants |  |  | 610,498 |  |  |  | 844,803 |
Restructuring costs |  |  | 24,638 |  |  |  | 933,732 |
Other |  |  | 908,247 |  |  |  | 835,409 |
Total |  | $ | 5,537,881 |  |  | $ | 5,837,044 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20, 24 -Article 5 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration